[1]
Palak, P. et al. 2025. Targeted Trigonelline Derivatives as Anti-Diabetic Agents: In-Silico Evaluation of Drug-Likeness, Safety and Efficacy. Journal of Neonatal Surgery. 14, 21S (May 2025), 1046–1064.